In a 55-year-old woman with an accidental overdose of long‑acting insulin, a forgotten ureteral stent placed two months ago, acute kidney injury, metabolic acidosis, leukocytosis, and urinary tract infection, does she require a Foley catheter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does this patient need a Foley catheter?

Yes, this patient requires urgent urinary drainage, but a Foley catheter is NOT the appropriate first-line intervention—she needs emergent ureteral decompression via retrograde ureteral stenting or percutaneous nephrostomy (PCN) to address the obstructive uropathy from the forgotten ureteral stent.

Primary Problem: Obstructive Uropathy with Infection

This patient's clinical picture—acute kidney injury, metabolic acidosis, leukocytosis, fever, and UTI in the setting of a forgotten ureteral stent placed two months ago—represents obstructive pyelonephritis/pyonephrosis, which is a urologic emergency requiring immediate decompression of the upper urinary tract, not simple bladder drainage.

Why Upper Tract Decompression is Critical

The forgotten ureteral stent is the root cause of her presentation. Retained ureteral stents cause:

  • Encrustation and stone formation 1
  • Ureteral obstruction leading to hydronephrosis
  • Ascending infection with potential for emphysematous complications 1
  • Progressive renal dysfunction 2

In obstructive pyelonephritis/pyonephrosis, urinary tract decompression is lifesaving 3. The evidence strongly supports that retrograde ureteral catheterization or PCN drainage is the appropriate first-line intervention in unstable patients or those with multiple comorbidities 3.

Treatment Algorithm

  1. Immediate Actions:

    • Start broad-spectrum IV antibiotics immediately (third-generation cephalosporin like ceftazidime is superior to fluoroquinolones for infected obstructed systems) 3
    • Obtain blood cultures and urine cultures
    • Urgent urology consultation
  2. Definitive Decompression (choose based on local expertise and patient stability):

    • Retrograde ureteral stenting: Usually appropriate for obstructive pyelonephritis with fever and leukocytosis 3
    • PCN (percutaneous nephrostomy): Equally appropriate alternative, particularly if retrograde access fails or patient is septic 3
    • Both approaches have similar efficacy; PCN may have higher technical success in cases of complete obstruction 3
  3. Stent Management:

    • The forgotten stent must be removed once acute infection is controlled 4
    • Ureteral stenting should be attempted for partial injuries; if unsuccessful, nephrostomy with delayed surgical repair is indicated 4

Role of Foley Catheter (Limited)

A Foley catheter alone will NOT address this patient's primary pathology because:

  • Her obstruction is at the ureteral level, not the bladder
  • The metabolic acidosis and AKI are from upper tract obstruction
  • Bladder drainage does not decompress an obstructed kidney

A Foley catheter may be placed as an adjunct for:

  • Monitoring urine output during resuscitation
  • Managing fluid status in the setting of AKI
  • However, it should be removed within 48 hours to minimize UTI risk 5, 6

The stroke guidelines emphasize that Foley catheters increase UTI risk when used >48 hours 5 and should be avoided whenever possible 6. In this patient with existing infection and sepsis risk, minimizing indwelling catheter time is crucial 7, 8.

Critical Pitfalls to Avoid

  • Do not delay upper tract decompression: Waiting for antibiotics alone to work in obstructive pyelonephritis can lead to sepsis and irreversible renal damage 3
  • Do not assume a Foley catheter is sufficient: This addresses the wrong anatomic level
  • Do not forget the forgotten stent: The retained stent is both the cause of obstruction and a nidus for persistent infection 1, 2
  • Monitor for post-obstructive diuresis: Once decompressed, she may have significant urine output requiring careful fluid management

Post-Decompression Management

After successful upper tract decompression:

  • Continue antibiotics for 7-10 days (adjust based on cultures) 9
  • Plan for definitive stent removal once infection clears
  • Monitor renal function recovery
  • If a temporary Foley was placed, remove it as soon as medically stable (ideally <48 hours) 5, 7

The key principle: treat the obstructed, infected kidney first through ureteral stenting or nephrostomy—this is what will reverse her AKI, clear her infection, and potentially save her renal function 3, 4.

References

Guideline

acr appropriateness criteria® radiologic management of urinary tract obstruction.

Journal of the American College of Radiology, 2020

Guideline

kidney and uro-trauma: wses-aast guidelines.

World Journal of Emergency Surgery, 2019

Related Questions

In a 40‑year‑old man weighing 73 kg with type 1 diabetes, creatinine 1.24 mg/dL, eGFR 75 mL/min, currently on insulin glargine (Lantus) 14 U daily and fixed bolus doses of insulin aspart (Novolog) 18 U at breakfast, 14 U at lunch, and 10 U at dinner, who received dexamethasone 6 mg 24 hours ago and is now started on continuous insulin infusion (CII), what should his insulin glargine (Lantus) dose, insulin‑sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) be?
In a 40‑year‑old man with type 1 diabetes, weight 73 kg, mild acute kidney injury (creatinine 1.24 mg/dL, eGFR 75 mL/min), currently receiving insulin glargine (Lantus) 14 U daily and a fixed‑meal rapid‑acting insulin aspart (Novolog) regimen totaling 56 U per day, who was given dexamethasone 36 hours ago and is now on an intravenous insulin infusion of 2.5 U per hour, what should his insulin glargine dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) be?
What should be the basal insulin glargine (Lantus) dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) for a 40‑year‑old man with type 1 diabetes, weight 73 kg, chronic kidney disease (creatinine 1.24 mg/dL, eGFR ≈ 75 mL/min) and a small acute kidney injury, who is on Lantus 14 U and fixed‑meal insulin lispro (Novolog) 18 U breakfast, 14 U lunch, 10 U dinner, received dexamethasone 48 hours ago, and required 2.5 U via IV insulin drip?
In a 44-year-old patient with bilateral double‑J ureteral stents who has painful stents and a urinalysis showing more than 250 white blood cells, what is the appropriate management?
How should a 20-year-old female with a painful flank suggestive of acute pyelonephritis be evaluated and treated?
Which ICD‑10‑CM code should be used for a patient presenting with no complaints?
For a patient on Geodon (ziprasidone) 40 mg twice daily with akathisia, who will be reduced to 20 mg twice daily and start olanzapine 10 mg at bedtime, how long should the taper continue before the Geodon can be completely discontinued?
What is the recommended management for a 46-year-old male with a right ankle sprain?
What are the causes of abnormal muscle twitching (fasciculations) in an elderly patient with dementia?
For a terminally ill patient allergic to lorazepam (which worsens restless legs), tolerating clonazepam, and receiving liquid morphine, what sublingual medication can be used to manage anxiety?
What is the acute management of atrial flutter?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.